Iovance Biotherapeutics (IOVA) Return on Sales (2023 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Return on Sales of 0.01% for Q1 2026, up 1.0% year-over-year from 0.01% in Q1 2025, and down 1226.38% quarter-over-quarter from 0.0% in Q4 2025.
Iovance Biotherapeutics (IOVA) Return on Sales (2023 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Return on Sales for 4 consecutive years, with 0.01% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Sales rose 1.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (up 1.0% YoY), while the FY2025 annual figure was 0.01%, up 1.0% from the prior year.
- Return on Sales retreated to 0.01% in Q1 2026 per IOVA's latest filing, from 0.0% in the prior quarter.
- Across five years, Return on Sales topped out at 0.0% in Q4 2025 and bottomed at 4.48% in Q2 2023.
- Historically, Return on Sales has averaged 0.92% across 4 years, with a median of 0.02% in 2025.
- Annual changes were most pronounced in 2024 — Return on Sales jumped 444 bps — and 2025, when it changed 0 bps.
- Iovance Biotherapeutics' Return on Sales stood at 2.41% in 2023, then jumped by 100 bps to 0.01% in 2024, then jumped by 109 bps to 0.0% in 2025, then slumped by 1226 bps to 0.01% in 2026.
- Business Quant data shows IOVA's Return on Sales at 0.01% in Q1 2026, 0.0% in Q4 2025, and 0.01% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.03% |
| Mar 31, 2024 | -1.58% |
| Dec 31, 2023 | -2.41% |
| Sep 30, 2023 | -2.43% |
| Jun 30, 2023 | -4.48% |